Chairman and CEO of Abbott Laboratories (ABT, Financial) Miles D White bought 1,281,500 shares of ABT on 07/25/2016. The total cost of this purchase was $45,508,124.26 (excluding taxes and fees/commissions).
Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States. Abbott Laboratories has a market cap of $64.16 billion; its shares were traded at around $43.67 with a P/E ratio of 28.91 and P/S ratio of 3.19. The dividend yield of Abbott Laboratories stocks is 2.32%.
For the complete insider trading history of ABT, click here.
